China SXT Pharmaceuticals receives noncompliance notification from Nasdaq

China SXT Pharmaceuticals announced that on October 3, the company received a notification letter from Nasdaq notifying the company that the minimum bid price per share for its ordinary shares has been below $1.00 for a period of 30 consecutive business days and the company therefore no longer meets the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2).